Viewing nowCombinationJardiance Duo Tablet 12.5/500 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201600388 · Approved 2016.01.21 · Insurance code 653501530
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with empagliflozin and metformin to improve blood glucose control in adults with type 2 diabetes. It is administered as an adjunct to dietary and exercise therapy for patients whose blood glucose levels are not adequately controlled. It is also effective for patients with type 2 diabetes who have cardiovascular diseases, although caution is needed regarding the potential for cardiovascular events. For detailed information related to this, please refer to the information for healthcare professionals. Therefore, this medication primarily helps in managing blood glucose levels and maintaining cardiovascular health in patients with type 2 diabetes.
The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication aids in blood glucose control but could rarely cause serious side effects like lactic acidosis, requiring caution. When taken with other diabetes medications, there is a risk of hypoglycemia, so blood glucose levels should be closely monitored. It should not be administered to patients with moderate to severe renal impairment, acute kidney issues, severe infections, heart failure, or acute myocardial infarction. Medication should be discontinued before and after tests using iodine-containing contrast agents, resuming only when kidney function is confirmed to be normal. It is not recommended for use in pregnant or breastfeeding women, nor in children under 18 years of age. During treatment, attention should be paid to signs of fluid loss or dehydration, liver dysfunction, hypoglycemia symptoms, urinary tract infections, and genital infections. Elderly patients or those with reduced kidney function should have regular kidney function tests and may require dose adjustments when used with insulin or sulfonylurea due to hypoglycemia risk. Moreover, this medication may reduce vitamin B12 levels, so monitoring vitamin B12 status during prolonged use is advised. In cases of overdose, the risk of lactic acidosis is present, requiring immediate notification to healthcare providers, with treatment potentially involving dialysis. Alcohol consumption should be avoided during treatment, and medication may need to be discontinued based on symptoms. Finally, if symptoms such as fever, pain in the genitals or perineum, redness, or swelling occur during treatment, immediate consultation with healthcare providers is necessary, as this can indicate a serious infection needing prompt treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. This will ensure that the chemical composition remains stable and safe for use.
Light brownish-purple, oval-shaped, biconvex film-coated tablet
60 tablets/box [10 tablets/PTP × 6 packs]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.